Although cigarette smoking is considered a major risk factor for several human diseases, the effects of smoking on male fertility are controversial. Studies on the consequences of smoking, which also take into account genetic background, may facilitate understanding of the interactions between genes and smoking and their effects on male fertility. In this study, genetic variants of two functional polymorphisms of erythroid 2-related factor 2 (NRF2), mRNA expression levels of the antioxidant gene NRF2, catalase (CAT), superoxide dismutase isoenzyme-2 (SOD2), glutathione S-transferase-M1 (GSTM1), and seminal SOD activities were compared in 314 heavy smokers and 314 matched nonsmokers. The NRF2 rs6721961 TT genotype was found to be associated with low semen quality in heavy smokers (OR [95% CI] ¼ 2.370 [1.106-5.081]). This variant genotype was found more frequently in heavy smokers with low semen quality than in those with high semen quality (P ¼ 0.011). Heavy smokers with this genotype had significantly lower sperm concentrations and sperm counts (P , 0.05) when compared with those without this genotype. Smoking was also significantly associated with decreased seminal SOD activity (P , 0.05) and reduced NRF2 and SOD2 mRNA expression in heavy smokers with this variant genotype. These results were specific to heavy smokers with the NRF2 rs6721961 TT genotypes, but did not apply to nonsmokers or heavy smokers that did not carry this genotype. This study suggests an association between cigarette smoking in heavy smokers with NRF2 rs6721961 TT genotype and a decrease in semen quality.
INTRODUCTION
Infertility affects 10%-15% of couples worldwide, and the male factor accounts for about half of infertility problems [1, 2] . Decreased semen quality has been confirmed by epidemiological studies [3, 4] ; however, the reasons for the decline in male fecundity are still largely unknown. Cigarette smoke contains high concentrations of nitric oxide, peroxynitrite, and free radicals, and can potentially induce the production of cellular reactive oxygen species (ROS) in the human body [5, 6] . Human spermatozoa are especially prone to oxidative damage due to the high content of polyunsaturated fatty acids on their plasma membranes [7] ; thus, it is possible that cigarette smoking is associated with decreased semen quality in humans [8] . However, even with the high risk of increased ROS exposure due to cigarette smoke, the incidence of male infertility among smokers has not yet been elucidated. Some studies have reported that cigarette smoking can significantly decrease basic semen parameters [9] [10] [11] , whereas other studies have shown that cigarette smoking does not affect semen quality [12, 13] .
The signaling pathway of erythroid 2-related factor 2 (NRF2)-antioxidant response element (ARE) plays a key role in response to oxidative stress. NRF2 is a transcription factor that promotes the expression of many critical antioxidant genes [14] . The induction of cytoprotective and antioxidant enzymes, such as catalase (CAT), superoxide dismutase (SOD) isoenzymes, and glutathione S-transferases (GSTs), is mediated largely by NRF2 [15, 16] . The NRF2-ARE signaling pathway has been reported to be associated with a wide spectrum of diseases in human and animal models, including lung diseases, cerebral ischemia, and eye diseases [17] [18] [19] . Recently, experiments done in a mice model have demonstrated that this gene is also associated with spermatogenesis [20] .
A single-nucleotide polymorphism (SNP) in the NRF2 promoter, rs6721961, was located in an ARE-like element that can bind to the NRF2 protein. Another SNP, rs35652124, has been found in a transcriptional factor called the myeloid zinc finger gene 1 (MZF1) binding site [21] . In vitro assays have indicated that compared to the wild type, polymorphisms in the two NRF2 sites had significantly decreased transcriptional capabilities [21, 22] . These functional polymorphisms of NRF2 have been linked to the risk of human ulcerative colitis, postmenopausal breast cancer, and acute lung injury [21, 23, 24] . Our recent work also suggested that these two NRF2 genotypes increased the risk of human oligoasthenozoosper-mia, a severe male infertility syndrome [22] . However, it is not known whether the NRF2 gene and smoking have any synergistic effect on the pathogenesis of male infertility.
Studies of the consequences of smoking on the male reproductive system, which take genetic background into account, may facilitate understanding of the mechanisms involved in the effects of cigarette smoking on human spermatogenesis. In this paired case-control study, we evaluated the synergistic effect of cigarette smoking and functional NRF2 polymorphisms on human semen quality. Genetic variants of two functional polymorphisms located in the NRF2 promoter region (rs6721961 and rs35652124) were genotyped, and the mRNA expression levels of antioxidant genes NRF2, CAT, SOD2, and GSTM1 were measured in 314 heavy smokers and in 314 matched nonsmokers. Activity levels of seminal SOD isoenzymes were also assayed. The basic semen parameters, distribution frequencies of NRF2 genotypes, antioxidant enzyme activities, and antioxidant gene expression levels were compared between the two groups. The results indicated that cigarette smoking may be associated with semen quality in men bearing specific NRF2 genotypes, suggesting that antioxidant genes and smoking have a synergistic effect on human spermatogenesis.
MATERIALS AND METHODS

Study Subjects
This study was approved by the institutional review board of Guangzhou Medical University and the medical ethics committee of Zhongshan School of Medicine of Sun Yat-Sen University. All studies involving human subjects were conducted in accordance with the Declaration of Helsinki guidelines. Participants in this study were scheduled for interviews after written, informed consent was obtained. The interviewers collected data regarding medical history, lifestyle, and smoking status via a structured questionnaire. Smoking pack-years was calculated by multiplying the smoking dose (packs per day) by the duration (years smoked). Current smokers with a smoking dose !1 pack per day over 10 yr or a smoking dose !2 packs per day over 5 yr were defined as heavy smokers. Individuals who had never smoked were defined as nonsmokers.
Study subjects were ethnic Han Chinese from Guangzhou City and its surrounding regions in South China. Subjects were males who had visited the Reproductive Medicine Center in the Third Affiliated Hospital of Guangzhou Medical University for infertility consultation between November 2010 and May 2012. All subjects underwent physical examinations and had at least two semen analyses. Men who were unhealthy or that had a known cause for defective spermatogenesis, such as varicocele, infection, obstruction of the vas deferens, chromosomal abnormalities, or microdeletions in the azoospermia factor region on the Y chromosome, were excluded. Patients who were diagnosed with severe oligozoospermia (sperm concentration ,5 3 10 6 cells per milliliter), azoospermia, hemospermia, leukospermia, and necrozoospermia [25] were also excluded, since there were likely genetic or medical reasons for the low sperm quality. A total of 314 heavy smokers and 314 matched nonsmokers were included in this study.
Heavy smokers and nonsmokers were further divided into three groups based on World Health Organization (WHO) criteria [25] for semen quality: low (L), medium (M), and high (H). Men who had sperm concentrations 15 3 10 6 cells per milliliter or sperm progressive motility 32% were placed in the L group. They were classified as idiopathic asthenozoospermic, oligozoospermic, or oligoasthenozoospermic patients based on the criteria from the WHO manual, fifth edition [25] . Men who had sperm concentrations !35 3 10 6 cells per milliliter (33rd percentile, total worldwide population) and sperm progressive motility !50% (normal motility cutoff as given in the WHO fourth edition criteria) [26] were placed in the H group, and were considered normozoospermic males. Men who had sperm concentrations between 15 3 10 6 and 35 3 10 6 cells per milliliter or sperm progressive motility between 32% and 50% were placed in the M group and were considered to have marginal semen quality.
Semen Collection and Analysis
Semen samples were collected in sterile containers from patients by masturbation after 2-7 days of sexual abstinence. Samples were allowed to liquefy for at least 30 min at room temperature. Analysis of semen volume, pH, sperm concentration, vitality, motility, and computer-assisted semen analysis were carried out according to WHO guidelines [25] . Samples were centrifuged at 1000 3 g for 10 min, and seminal plasma and cell pellets were separated and stored at À808C until analysis.
Genotyping Analysis of the NRF2 Promoter
Genomic DNA was isolated from sperm cells using a QIAamp DNA Mini Kit (Qiagen GmbH, Hilden, Germany) with a modified protocol. Briefly, 100 ll of cell pellet separated from semen samples was mixed with 100 ll buffer (containing 20 mM Tris, 20 mM ethylenediaminetetraacetic acid, 200 mM NaCl, 80 mM dithiothreitol, 4% SDS, and 250 lg/ml proteinase K) in a 1.5-ml microcentrifuge tube. The mixture was incubated at 568C overnight until the cells were completely dissolved. DNA was extracted in accordance with the protocol included in the QIAamp kit, and about 100 ng of genomic DNA was used for PCR with primers of GACCACTCTCCGACCTAAAGG and AGGGAGCTCCAAGTCCAT. The amplified region was from À1041 to À318 in the NRF2 gene promoter. Finally, PCR products were purified and sequenced to determine the genotype.
SOD Enzyme Activity
Total SOD activity was assayed using an SOD assay kit per the manufacturer's instructions (Sigma). Briefly, 20 ll of seminal plasma (diluted 1:20) was added to one well of a 96-well plate, and 200 ll of working solution plus 20 ll of xanthine oxidase enzyme working solution was added to each well. After mixing, the plate was incubated at 378C for 20 min. The absorbance was recorded at 450 nm, and total SOD activity (inhibition rate percentage) was calculated. The protein concentration of each sample was determined using a BCA assay (Pierce). The assay was finally calibrated using a commercial SOD enzyme (Sigma), and the total SOD activity of each sample was converted to units per milligram of total proteins in seminal plasma (U/mg).
Quantitative Real-Time RT-PCR
Total RNA was extracted from frozen spermatozoa using Trizol reagent (Invitrogen) according to the manufacturer's instructions. All RNA was reverse-transcribed and subjected to PCR with SYBR real-time PCR reagent (Takara) in the Bio-Rad IQ5 (Bio-Rad). Data were analyzed using CFX Manager software (Bio-Rad). The primers for NRF2 (5-TTCAGCCAGCC CAGCACATC-3 and 5-CGTAGCCGAAGAAACCTCATTGTC-3), CAT (
5-G T T A C T C A G G T G C G G G C A T T C T A T -3 a n d 5 -G A A G T T C T T GACCGCTTTCTTCTG-3), GSTM1
(5-CAGTCAGCCGCATCTTCTTT-3 and 5-CGCCCAATACGACCAAATC-3), and SOD2 (5-GTGGAGAACC CAAAGGGGAGTT-3 and 5-GTGGAATAAGGCCTGTTGTTCCTT-3) were taken from previous designs and used for the amplification of human mRNA [27] [28] [29] . The average of three independent measurements was used to calculate the transcription levels of target genes relative to the transcription levels of the housekeeping gene GAPDH (5-TGGTGAAGGTCGGTGTGAAC-3 and 5-CCATGTAGTTGAGGTCAATGAAGG-3).
Statistical Analysis
The chi-square test was used to compare groups of categorical variables, and an independent sample t-test was used to analyze numerical data in two groups. The Spearman test was used to calculate correlations, and the nonparametric Mann-Whitney test was used to analyze differences between nonhomogeneous variances. One-way ANOVA with Tukey or Dunnett posttest was used to analyze data in multiple groups. Associations between genotypes and semen quality were estimated using an unconditional logistic regression model adjusted for age. All analyses were performed using GraphPad Prism 4.0 for Windows (GraphPad Software) and the PASW Statistics 18 (SPSS Inc.). A two-sided P value of 0.05 was considered statistically significant.
RESULTS
Clinical Data of Study Subjects
Age, smoking status, and basic semen parameters of the heavy smokers (n ¼ 314) and the nonsmokers (n ¼ 314) are shown in Table 1 . There were no significant differences in age or basic semen parameters, such as concentration, volume, progressive motility rate, immotility rate, and viability, between the two groups ( Table 1) .
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Genotype Analysis of NRF2 Promoter in Heavy Smokers and Nonsmokers
Two known functional SNPs in the NRF2 promoter region, rs6721961 G . T and rs35652124 T . C, were identified in all subjects. The frequencies of the different rs6721961 and rs35652124 genotypes were similar between the heavy smokers and the nonsmokers (Table 2 ). However, after subjects were further stratified into L, M, and H groups according to semen quality, the rs6721961 genotype showed different distribution patterns between heavy smokers and nonsmokers. Statistical analysis showed the frequencies of the rs6721961 TT genotype to be 15.2%, 9.8%, and 5.3% in the L, M, and H groups of smokers, respectively (Table 2) . Among heavy smokers, there were significant differences in the frequencies between the L and H groups (P ¼ 0.011) and between the H group and the L and M groups combined (P ¼ 0.027; Table 2 ). The frequencies of the rs6721961 T allele were also significantly different between the H group and the L and M groups combined (P ¼ 0.045). The frequencies were marginally different between the H and L groups and those between the H and M groups (P ¼ 0.110 and P ¼ 0.068; Table 2) . Unconditional logistic regression analysis demonstrated that the NRF2 rs6721961 TT genotype was significantly associated with low semen quality in heavy smokers, after adjustment for age (P ¼ 0.027, OR ¼ 2.370, 95% CI ¼ 1.106-5.081; Table 3 ). None of these differences or associations were found when comparing the L, M, and H subgroups in nonsmokers (Tables 2  and 3 ). Also, no differences or associations were observed in the frequency distributions of the rs35652124 genotypes among the different subgroups of heavy smokers or nonsmokers (Tables 2 and 3) .
Effects of NRF2 Genotypes on Semen Quality in Heavy Smokers and Nonsmokers
Heavy smokers were divided into four groups according to NRF2 rs6721961 genotype: all subjects (subjects with all kinds of genotypes), subjects with the GG genotype, subjects with the GT genotype, and subjects with the TT genotype. Subjects with the TT genotype had a significantly lower level of semen quality than did the other three groups (Table 4) . Sperm concentrations in the all-subjects, GG, GT, and TT groups were 73. 6 (Table 4 ). Both parameters were significantly lower in the TT group compared to the other groups (P , 0.05). The sperm progressive motility and immotility rates were also different in the TT group compared with those of the all-subjects group (38% and 55% vs. 45% and 48%, respectively; Table 4 ). However, in nonsmokers, none of the semen parameters were statistically different between the four groups (Table 5) .
Seminal SOD Activity in Heavy Smokers and Nonsmokers
Total SOD activity in the seminal plasma of both heavy smokers and nonsmokers was assayed (Fig. 1) . In heavy smokers, the average activity levels were 2.81, 2.95, 2.82, and 2.28 U/mg in the all-subjects, GG, GT, and TT groups, respectively. The SOD activity in smokers with the TT genotype was significantly lower than in the other three groups (P , 0.05; Fig. 1A ). There were no significant differences in average activity levels between the four groups of nonsmokers (2.85, 2.74, 2.93, and 2.98 U/mg, respectively; Fig. 1B) .
Expression of Antioxidant Genes in Spermatozoa of Heavy Smokers and Nonsmokers
To determine whether antioxidant gene expression in spermatozoa is related to smoking status and NRF2 genotype, the mRNA levels of NRF2, CAT, GSTM1, and SOD2 in spermatozoa from different individuals were measured. The 
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mRNA levels in spermatozoa of 29 nonsmokers (nine men with rs6721961 TT and 20 men with GG) and 35 heavy smokers (10 men with rs6721961 TT and 25 men with GG) were successfully measured using real-time RT-PCR. The data indicated that there were no significant differences in the expression of CAT and GSTM1 genes between heavy smokers and nonsmokers (Fig. 2, B and C) . However, heavy smokers tended to have lower NRF2 mRNA levels than did nonsmokers, though the P value was marginal (P ¼ 0.0628; Fig. 2A ). The level of SOD2 mRNA was significantly lower in heavy smokers with the TT genotype than in their nonsmoking counterparts (P , 0.05); however, this was not observed when 
a All, all subjects; GG, subjects with rs 6721961GG genotype; GT, subjects with rs 6721961GT genotype; TT, subjects with rs 6721961TT genotype. * P , 0.05 compared with All, GG, and GT groups. a All, all subjects; GG, subjects with rs 6721961GG genotype; GT, subjects with rs 6721961GT genotype; TT, subjects with rs 6721961TT genotype.
FIG. 1.
Seminal SOD activity in heavy smokers (A) and nonsmokers (B) with different NRF2 promoter genotypes. ALL, all subjects; GG, subjects with rs 6721961GG genotype; GT, subjects with rs 6721961GT genotype; TT, subjects with rs 6721961TT genotype. *P , 0.05 compared to ALL, GG, and GT groups in heavy smokers.
comparing heavy smokers to nonsmokers with the GG genotype (Fig. 2D) .
DISCUSSION
Although cigarette smoking is a major risk factor for several human diseases, such as lung cancer and chronic obstructive pulmonary disease (COPD) [30, 31] , the effects of cigarette smoking on male fertility have not yet been clarified and are still controversial [9, 10, 12, 13, 32] . The effect of smoking on semen quality is difficult to discern due to confounding effects such as the smoking habits of a partner, environmental factors, and genetic background. Therefore, studies of the consequences of smoking on the male reproductive system that take genetic background into account, particularly with respect to the genes involved in antioxidant defense, may facilitate understanding of the interactions between genetic variability and smoking and their potential synergetic effects on male fertility.
In the current study, the means by which genetic variations in the antioxidant pathway might contribute to susceptibility to smoking-related male infertility were explored. Genotyping data showed the rs6721961 TT variant genotype to be more abundant in heavy smokers with low semen quality compared with heavy smokers with high semen quality and nonsmokers with low semen quality ( Table 2 ). This suggests a potential synergistic effect of NRF2 functional polymorphisms and smoking on human semen quality. Previous studies have suggested that the oxidative stress imposed by smoking has only a small impact on DNA damage and the antioxidant system [33, 34] . However, if preimposed genetic variations in the antioxidant pathway are involved, the effects of smoking might be amplified, as implied by the results of the current study. Several reports have demonstrated that interactions between genes and environmental factors could be the etiology of male infertility [35, 36] . One study reported that high levels of exposure to polycyclic aromatic hydrocarbons could amplify the effects of genetic polymorphisms of the X-ray repair crosscomplementing group 1 gene (XRCC1) on male infertility and sperm DNA damage [35] . Another study indicated a possible interaction between the SOD2 V16A genotype and smoking in the development of male infertility [36] . The results of the present work demonstrate that NRF2 promoter polymorphisms might alter smoking-related susceptibility to male infertility. Heavy smokers with the rs6721961 TT genotype had a 2.37-fold higher risk of developing low semen quality than those , GSTM1 (C), and SOD2 (D) to GAPDH in nonsmokers (white column) and smokers (black column) were presented. ALL, all subjects; TT, subjects with rs 6721961TT genotype; GG, subjects with rs 6721961GG genotype. *P , 0.05 compared to the GG group in heavy smokers. # P ¼ 0.0628 compared to the ALL group in nonsmokers.
EFFECTS OF SMOKING AND NRF2 SNP ON SEMEN QUALITY without this genotype ( Table 3 ). Given that both genetic and environmental factors are important to human spermatogenesis, understanding the synergistic effects of genetic variation and cigarette smoking on semen quality might facilitate the development of new preventive and therapeutic responses to male infertility.
The data in this study showed that the combination of smoking and the rs6721961 TT genotype caused major decreases in sperm concentration and sperm count ( Table 4 ), indicating that the two factors adversely affected testicular spermatogenesis in humans. Nakamura et al. [20] reported that, in mice, the rate of the decline in sperm counts attributable to NRF2 gene deficits was higher than the rate of decline in sperm motility. Their data showed that sperm counts were significantly decreased when the mice were 4 mo old, but that motility did not significantly decrease until 6 mo of age, suggesting independent effects of the NRF2 gene on the testis and epididymis [20] . Generation of sperm in the testis and maturation of sperm in the epididymis are two stages in spermatogenesis; thus, Nakamura's results and those of the present study suggest that the NRF2 gene affects both stages. The generation of spermatozoa in the testis produces large amounts of ROS. Sperm cells in the epididymis are susceptible to ROS, which can cause loss of motility and subsequent cell death. Therefore, deficiencies in antioxidant capability and increases in exogenous ROS may lead to lesions both in the testis and in the epididymis. However, more studies are needed in order to elucidate the synergistic effects of smoking and functional polymorphisms in antioxidant genes on the different stages of spermatogenesis.
Cigarette smoke is a potent source of oxidants, which attack the nucleophilic groups in cellular proteins. It has been reported that cysteine residues in histone deacetylase 2 (HDAC2) can be S-nitrosylated in either peripheral lung tissues isolated from smokers with COPD or cells exposed to cigarette smoke condensate in vitro [37] . In this study, SOD activity was found to be lower in heavy smokers than in nonsmokers, indicating that smoke had adverse effects on antioxidant enzymes (Fig. 1) . This finding was consistent with an early study that reported a negative association between SOD levels and cigarette smoking [38] .
The molecular mechanisms underlying smoking-induced decreases in antioxidant enzyme activity are still under investigation. It has been assumed that smoking may affect semen quality either by modifying important enzymes or by interfering with signaling pathways. In one study conducted in COPD patients, it was suggested that the loss of regulator and degradation of the NRF2 proteins caused by cigarette smoking might impair antioxidant induction [39] . Because SOD isoenzymes contain many nucleophilic groups, they can be modified by the electrophiles in cigarette smoke. It is also possible that smoke decreases the expression of the antioxidant genes NRF2 and SOD, thus lowering the levels of SOD isoenzyme expression. Previous studies have reported that prolonged cigarette smoke exposure can alter the mRNA expression of HO-1, NRF2, and BACH1 in human macrophages [40] , and that heavy smoking can decrease the mRNA expression of NRF2 and glutathine in human peripheral blood mononuclear cells and plasma [27] . Our data also demonstrate that smoking may decrease NRF2 and SOD2 mRNA expression in human spermatozoa (Fig. 2) . Therefore, smoking might interfere with the NRF2-ARE pathway at the mRNA expression level, leading to smoking-related spermatogenesis impairment.
In conclusion, this study indicates that cigarette smoking in heavy smokers with certain genetic polymorphisms, such as the NRF2 rs6721961 TT genotype, is associated with a decrease in semen quality. Heavy smokers with this genotype had a decreased sperm concentration and sperm count, as well as adverse effects on sperm motility. Heavy smoking was also associated with decreased antioxidant enzyme SOD activity in the seminal plasma and reduced SOD2 mRNA expression. These results were specific to heavy smokers with the rs6721961 TT genotype, as none of them were observed in nonsmokers or in heavy smokers who did not carry this genotype. Therefore, cigarette smoking and the NRF2 rs6721961 TT genotype might synergistically affect human semen quality. This investigation revealed a novel interaction between genes and smoking in human spermatogenesis, providing one possible explanation for the lack of consistency found in the previous studies on the consequences of smoking in male reproduction. Results from this study may contribute to our understanding of the role of NRF2 in ROS induced by cigarette smoke and of related impairments in spermatogenesis. However, since this study was restricted to a hospital-based Chinese Han population, selection bias was unavoidable. These findings should be validated in general population-based studies that include different ethnic groups.
